BRAIN Study

Summary

The purpose of this study is to try and understand how the adolescent brain responds to pain. The first part of the study involves teens filling out an online questionnaire, which asks about pain, sleep and mental health. They will receive a $10 gift card for answering this questionnaire.

One week later, we will have the teen come to the Alberta Children's Hospital. Using a device that applies thermal heat, we will establish their threshold for low, medium and high heat on their forearm. We will then apply 3 creams to their forearm: 1) one will enhance sensitivity to pain; 2) one will have no effect on pain; and 3) one will decrease sensitivity to pain. We will test their responses to the creams both outside and inside the MRI. Transportation to and parking at the hospital will be reimbursed via gift card. Teens will receive an additional $20 gift card and pictures of their brain to thank them for participating in this study.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 14 to 18

Accepts healthy participants: Yes

Inclusion criteria:

Inclusion criteria include:
1) Healthy adolescents aged 14-18 years
2) Ability to read and speak English
3) No neurodevelopmental disorders
4) No neuropsychiatric disorders
5) No neuropsychotropic medication
6) No chronic medical conditions

Exclusion criteria:

Potential participants with any of the following will be excluded:
1) History of chronic pain
2) Significant head trauma
3) Diagnosed neurological, developmental, or psychiatric disorder
4) Alcohol or substance use problem
5) Major chronic medical disease
6) Pregnancy
7) Contraindications to MRI (e.g., braces, claustrophobia).

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Dr. Jill Miller Assistant Professor, Neuroscience Department of Anesthesiology, Perioperative & Pain Medicine Cumming School of Medicine, University of Calgary

Principal investigator:

Jillian Miller

Clinical trial:

No

REB-ID:

REB22-1633